Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 1
2004 1
2006 1
2007 1
2008 1
2009 1
2010 4
2011 6
2012 14
2013 12
2014 7
2015 13
2016 11
2017 10
2018 8
2019 11
2020 16
2021 13
2022 12
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26700639

141 results

Results by year

Filters applied: . Clear all
Page 1
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
Kaleebu P, Kirungi W, Watera C, Asio J, Lyagoba F, Lutalo T, Kapaata AA, Nanyonga F, Parry CM, Magambo B, Nazziwa J, Nannyonjo M, Hughes P, Hladik W, Ruberantwari A, Namuwenge N, Musinguzi J, Downing R, Katongole-Mbidde E; HIV Drug Resistance Working group. Kaleebu P, et al. PLoS One. 2015 Dec 23;10(12):e0145536. doi: 10.1371/journal.pone.0145536. eCollection 2015. PLoS One. 2015. PMID: 26700639 Free PMC article.
Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
Musengimana G, Tuyishime E, Kiromera A, Malamba SS, Mulindabigwi A, Habimana MR, Baribwira C, Ribakare M, Habimana SD, DeVos J, Mwesigwa RCN, Kayirangwa E, Semuhore JM, Rwibasira GN, Suthar AB, Remera E. Musengimana G, et al. Antivir Ther. 2022 Jun;27(3):13596535221102690. doi: 10.1177/13596535221102690. Antivir Ther. 2022. PMID: 35593031 Free PMC article.
Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda.
Ndahimana Jd, Riedel DJ, Mwumvaneza M, Sebuhoro D, Uwimbabazi JC, Kubwimana M, Mugabo J, Mulindabigwi A, Kirk C, Kanters S, Forrest JI, Jagodzinski LL, Peel SA, Ribakare M, Redfield RR, Nsanzimana S. Ndahimana Jd, et al. Trop Med Int Health. 2016 Jul;21(7):928-35. doi: 10.1111/tmi.12717. Epub 2016 Jun 13. Trop Med Int Health. 2016. PMID: 27125473 Free article.
Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda.
Rusine J, Asiimwe-Kateera B, van de Wijgert J, Boer KR, Mukantwali E, Karita E, Gasengayire A, Jurriaans S, de Jong M, Ondoa P. Rusine J, et al. PLoS One. 2013 Aug 12;8(8):e64345. doi: 10.1371/journal.pone.0064345. eCollection 2013. PLoS One. 2013. PMID: 23950859 Free PMC article.
High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
Segujja F, Omooja J, Lunkuse S, Nanyonjo M, Nabirye SE, Nassolo F, Bugembe DL, Bbosa N, Kateete DP, Ssenyonga W, Mayanja Y, Nsubuga RN, Seeley J, Kaleebu P, Ssemwanga D. Segujja F, et al. AIDS Res Hum Retroviruses. 2020 Sep;36(9):782-791. doi: 10.1089/AID.2019.0279. Epub 2020 Jun 25. AIDS Res Hum Retroviruses. 2020. PMID: 32475121
Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.
Hong SY, Jonas A, DeKlerk M, Shiningavamwe A, Desta T, Badi A, Morris L, Hunt GM, Ledwaba J, Sheehan HB, Lau K, Trotter A, Tang AM, Wanke C, Jordan MR. Hong SY, et al. J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):463-71. doi: 10.1097/QAI.0000000000000509. J Acquir Immune Defic Syndr. 2015. PMID: 25564107 Free PMC article.
Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
Fokam J, Santoro MM, Takou D, Njom-Nlend AE, Ndombo PK, Kamgaing N, Kamta C, Essiane A, Sosso SM, Ndjolo A, Colizzi V, Perno CF. Fokam J, et al. BMC Pediatr. 2019 Jul 5;19(1):226. doi: 10.1186/s12887-019-1599-z. BMC Pediatr. 2019. PMID: 31277610 Free PMC article.
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KC, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vugt M, de Wit TF; PharmAccess African Studies to Evaluate Resistance (PASER). Hamers RL, et al. Lancet Infect Dis. 2011 Oct;11(10):750-9. doi: 10.1016/S1473-3099(11)70149-9. Epub 2011 Jul 27. Lancet Infect Dis. 2011. PMID: 21802367
141 results